4.5 Article

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

Journal

EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 46, Issue -, Pages 39-48

Publisher

ELSEVIER
DOI: 10.1016/j.euroneuro.2021.03.019

Keywords

COVID-19; Cognitive impairment; Quality of life; Pulmonary dysfunction

Funding

  1. Department of Pulmonology Medicine and Respiratory Research Unit, Bispebjerg University Hospital
  2. Lundbeck Foundation for her fiveyear Lundbeck Foundation Fellowship [R215-2015-4121]

Ask authors/readers for more resources

This study investigated the frequency, pattern, and severity of cognitive impairments in patients 3-4 months after COVID-19 hospital discharge, finding that a majority of patients had clinically significant cognitive impairment. These impairments were associated with subjective cognitive complaints, lower quality of life, and illness variables. Further research is needed to understand the associations between cognitive sequelae of COVID-19 and lung affection, cerebral oxygen delivery, and targeted treatments for persistent cognitive impairments.
The ongoing Coronavirus Disease 2019 (COVID-19) pandemic has affected more than 100 million people and clinics are being established for diagnosing and treating lingering symptoms, so called long-COVID. A key concern are neurological and long-term cognitive complications. At the same time, the prevalence and nature of the cognitive sequalae of COVID-19 are unclear. The present study aimed to investigate the frequency, pattern and severity of cognitive impairments 3-4 months after COVID-19 hospital discharge, their relation to subjective cognitive complaints, quality of life and illness variables. We recruited patients at their follow up visit at the respiratory outpatient clinic, Copenhagen University Hospital, Bispebjerg, ap-proximately four months after hospitalisation with COVID-19. Patients underwent pulmonary, functional and cognitive assessments. Twenty-nine patients were included. The percentage of patients with clinically significant cognitive impairment ranged from 59% to 65% depending on the applied cut-off for clinical relevance of cognitive impairment, with verbal learning and executive functions being most affected. Objective cognitive impairment scaled with subjec-tive cognitive complaints, lower work function and poorer quality of life. Cognitive impair-ments were associated with d-dimer levels during acute illness and residual pulmonary dys-function. In conclusion, these findings provide new evidence for frequent cognitive sequelae of COVID-19 and indicate an association with the severity of the lung affection and potentially restricted cerebral oxygen delivery. Further, the associations with quality of life and func-tioning call for systematic cognitive screening of patients after recovery from severe COVID-19 illness and implementation of targeted treatments for patients with persistent cognitive impairments. (c) 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available